Page last updated: 2024-09-03

sr 48692 and mirtazapine

sr 48692 has been researched along with mirtazapine in 1 studies

Compound Research Comparison

Studies
(sr 48692)
Trials
(sr 48692)
Recent Studies (post-2010)
(sr 48692)
Studies
(mirtazapine)
Trials
(mirtazapine)
Recent Studies (post-2010) (mirtazapine)
2033361,538324646

Protein Interaction Comparison

ProteinTaxonomysr 48692 (IC50)mirtazapine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)0.0851
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.2239
Alpha-2B adrenergic receptorHomo sapiens (human)0.2239
Alpha-2C adrenergic receptorHomo sapiens (human)0.1995
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.2239
Alpha-1A adrenergic receptorHomo sapiens (human)3.1623
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.2239
TransporterRattus norvegicus (Norway rat)0.26

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robertson, VB; Wilson, MS1

Other Studies

1 other study(ies) available for sr 48692 and mirtazapine

ArticleYear
Neurotensin receptor agonists and antagonists for schizophrenia.
    The American journal of psychiatry, 2005, Volume: 162, Issue:3

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Data Interpretation, Statistical; Humans; Mianserin; Mirtazapine; Neurotensin; Peptide Fragments; Piperidines; Pyrazoles; Quinolines; Receptors, Neurotensin; Research Design; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2005